News
Psoriasis Market Outlook In The 7MM Through 2034: In-Depth Analysis By Psoriasis Type | Delveinsight
The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a dive ...
Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most ...
Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.
But when it comes to accessibility, there's still work to do. Products and packaging are designed for the able-bodied who can ...
1d
Verywell Health on MSNWhat Happens When You Take Turmeric and Apple Cider Vinegar Together?Together, turmeric and apple cider vinegar could have powerful health benefits. Learn how to incorporate this combo into your ...
Ultrasound-detected dactylitis lesions may help identify patients with psoriasis who are at risk for psoriatic arthritis and ...
2025 — People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for 'leaky gut', according to new research. These changes in ...
Arcutis Biotherapeutics, Inc.’s ARQT share price has surged by 5.09%, which has investors questioning if this is right time to sell.
The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the ...
4d
PsyPost on MSNChildhood maltreatment linked to higher risk of rheumatoid arthritis and psoriasis, study findsA new study published in Heliyon has found that people who experienced abuse, neglect, or domestic abuse during childhood ...
Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ex-Dermira executives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results